Shandong Sino-Agri United Biotechnology Co.,Ltd.
SZSE:003042.SZ
17.36 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,013.624 | 1,680.905 | 1,933.424 | 1,625.073 | 1,568.185 | 1,366.782 | 1,412.801 | 1,121.754 | 952.313 | 907.296 |
| Cost of Revenue
| 1,782.014 | 1,529.604 | 1,525.41 | 1,215.488 | 1,174.505 | 876.731 | 795.122 | 717.512 | 681.084 | 656.598 |
| Gross Profit
| 231.61 | 151.301 | 408.014 | 409.584 | 393.681 | 490.052 | 617.678 | 404.242 | 271.229 | 250.698 |
| Gross Profit Ratio
| 0.115 | 0.09 | 0.211 | 0.252 | 0.251 | 0.359 | 0.437 | 0.36 | 0.285 | 0.276 |
| Reseach & Development Expenses
| 85.702 | 98.484 | 103.911 | 73.633 | 64.808 | 61.347 | 70.572 | 51.588 | 0 | 0 |
| General & Administrative Expenses
| 36.395 | 42.769 | 34.804 | 38.888 | 28.634 | 35.438 | 41.793 | 29.692 | 104.959 | 87.715 |
| Selling & Marketing Expenses
| 18.092 | 61.071 | 45.139 | 45.416 | 38.13 | 62.604 | 62.485 | 57.098 | 41.297 | 35.963 |
| SG&A
| 54.487 | 103.84 | 79.942 | 84.304 | 66.765 | 98.042 | 104.278 | 86.79 | 146.256 | 123.678 |
| Other Expenses
| 227.03 | 186.215 | 121.978 | 112.618 | 91.714 | 145 | -5.43 | -2.609 | 0 | 0 |
| Operating Expenses
| 367.218 | 388.538 | 305.831 | 270.555 | 223.287 | 304.389 | 313.943 | 240.483 | 183.165 | 148.764 |
| Operating Income
| -135.608 | -237.237 | 106.794 | 108.934 | 119.404 | 162.545 | 283.025 | 126.656 | 119.987 | 125.604 |
| Operating Income Ratio
| -0.067 | -0.141 | 0.055 | 0.067 | 0.076 | 0.119 | 0.2 | 0.113 | 0.126 | 0.138 |
| Total Other Income Expenses Net
| -0.595 | 0.642 | -35.761 | -18.38 | -35.692 | -16.751 | -16.095 | -38.321 | -31.923 | -23.67 |
| Income Before Tax
| -136.204 | -236.595 | 71.033 | 108.902 | 118.843 | 162.688 | 277.595 | 124.047 | 88.064 | 101.934 |
| Income Before Tax Ratio
| -0.068 | -0.141 | 0.037 | 0.067 | 0.076 | 0.119 | 0.196 | 0.111 | 0.092 | 0.112 |
| Income Tax Expense
| -13.751 | -44.124 | -2.105 | 10.307 | 15.317 | 15.552 | 33.923 | 17.58 | 15.166 | 17.669 |
| Net Income
| -122.453 | -192.471 | 73.138 | 98.595 | 103.526 | 147.136 | 243.671 | 106.467 | 72.898 | 84.265 |
| Net Income Ratio
| -0.061 | -0.115 | 0.038 | 0.061 | 0.066 | 0.108 | 0.172 | 0.095 | 0.077 | 0.093 |
| EPS
| -0.86 | -1.35 | 0.51 | 0.69 | 1.24 | 1.89 | 3.29 | 1.13 | 1.04 | 1.28 |
| EPS Diluted
| -0.86 | -1.35 | 0.51 | 0.69 | 1.24 | 1.89 | 3.29 | 1.13 | 1.04 | 1.28 |
| EBITDA
| 80.147 | -39.156 | 252.439 | 245.84 | 250.167 | 284.291 | 391.988 | 228.582 | 185.238 | 169.183 |
| EBITDA Ratio
| 0.04 | -0.023 | 0.131 | 0.151 | 0.16 | 0.208 | 0.277 | 0.204 | 0.195 | 0.186 |